Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Larval settlement receptors are a functional class of sensory proteins, primarily G protein-coupled receptors (GPCRs), found on the sensory structures of marine invertebrate larvae such as barnacles, mussels, and corals [2]. These receptors play a pivotal role in the life cycle of these organisms by detecting specific environmental cues—such as surface-bound pheromones, microbial biofilms, or chemical signals—that indicate a suitable substrate for permanent attachment and metamorphosis [4]. Upon activation, these receptors initiate intracellular signaling cascades, often involving secondary messengers like cyclic AMP (cAMP) or calcium ions, which trigger the physiological and behavioral changes necessary for settlement [2]. In the maritime and biotechnology sectors, these receptors are primary targets for the development of antifouling agents aimed at preventing the colonization of ship hulls and underwater infrastructure by fouling organisms [1]. For instance, the drug medetomidine acts as a potent agonist of alpha-2 adrenergic-like receptors in barnacle larvae, inducing a state of hyperactivity that prevents the larvae from settling without causing lethality [3]. Understanding the molecular diversity and signaling mechanisms of these receptors is essential for creating environmentally benign antifouling solutions that minimize ecological impact [1].
Modulation of neuroreceptor signaling pathways (primarily GPCR-mediated) to inhibit or induce the transition from planktonic larvae to sessile adults.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Larval settlement receptor.